Beyond AirSTU:48L0 25 OCF Margin % is -259.27% as of Mar. 2026. GuruFocus rates STU:48L0 with a GF Score™ of 25/100 and a GF Value™ of €71.79. The stock has 7 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Beyond Air ranks worse than 89.83% on this metric.
The historical rank and industry rank for Beyond Air's OCF Margin % or its related term are showing as below:
STU:48L0'
s OCF Margin % Range Over the Past 10 Years
Min: -4832.96 Med: -1064.32 Max: 17.36
Current: -236.38
During the past 12 years, the highest OCF Margin % of Beyond Air was 17.36%. The lowest was -4832.96%. And the median was -1064.32%.
STU:48L0's OCF Margin % is ranked worse than 89.83% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 5.84
vs STU:48L0: -236.38
Beyond Air OCF Margin % Related Terms
Beyond Air OCF Margin % Historical Data
* Premium members only.
The historical data trend for Beyond Air's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:48L0 vs VVOS, TNON, BMRA: OCF Margin % Comparison
For the Medical Devices subindustry, Beyond Air's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beyond Air OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Beyond Air's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air (STU:48L0) has a OCF Margin % of -259.27% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Beyond Air and its competitors. According to the industry distribution chart, Beyond Air ranks #733 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 89.8%.
Is Beyond Air's OCF Margin % too high?
Beyond Air's current OCF Margin % is -259.27%. Based on the distribution chart, Beyond Air ranks #733 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beyond Air has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Beyond Air's OCF Margin % compare to VVOS and TNON?
According to the Medical Devices & Instruments industry distribution chart, Beyond Air ranks #733 out of 816 companies for OCF Margin %. This places Beyond Air in the lower half of its industry. The industry median OCF Margin % is 5.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.84, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Beyond Air and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beyond Air's current OCF Margin % is -259.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beyond Air stock overvalued right now?
Beyond Air (STU:48L0) has a current OCF Margin % of -259.27%. The stock's GF Value™ is €71.79, compared to a current price of €3.42 — trading 95.2% below its estimated fair value. The current OCF Margin % is -259.27%. Beyond Air's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Beyond Air (STU:48L0), the current OCF Margin % is -259.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beyond Air (STU:48L0) Overvalued in 2026?
Based on GuruFocus' analysis, Beyond Air stock appears to be undervalued.
The current stock price of €3.42 is trading 95.2% below its estimated GF Value™ of €71.79.
Key valuation signals for STU:48L0:
OCF Margin %: -259.27%
GF Value™: €71.79 vs. price of €3.42 (95.2% below fair value)
No single metric tells the full story. See the STU:48L0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
25GF Score
Get the complete analysis for STU:48L0
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:48L0 has been successfully added to your 
